Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Katherine B. Peters
ResearcherPublications, citations & collaboration network
Katherine B. Peters is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 441 works, 9,682 citations, an h-index of 46 and an i10-index of 122.
441
Works
9,682
Citations
46
h-index
122
i10-index
How has Katherine B. Peters's publication output changed over time?
ScholarIQpublication output · 1997–2023
Output grew200% over the shown period — from 1 works in 1997 to 3 in 2023.
1
1
1
2
2
1
3
1997201720182020202120222023
What are the most-cited papers on Katherine B. Peters?
ScholarIQmost cited works
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Annick Desjardins, Matthias Gromeier, James E. Herndon, Nike Beaubier, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea Muscat, Smita K. Nair, Katherine B. Peters, Dina Randazzo, John H. Sampson, Gordana Vlahovic, W.T.A. Harrison, Roger E. McLendon, David M. Ashley, Darell D. Bigner
New England Journal of Medicine. 2018812 CitationsOPEN ACCESS
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Ingo K. Mellinghoff, Martin J. van den Bent, Deborah T. Blumenthal, Mehdi Touat, Katherine B. Peters, Jennifer Clarke, Joe Mendez, Shlomit Yust‐Katz, Liam Welsh, Warren Mason, François Ducray, Yoshie Umemura, Burt Nabors, Matthias Holdhoff, Andreas F. Hottinger, Yoshiki Arakawa, Juan Manuel Sepúlveda-Sánchez, Wolfgang Wick, Riccardo Soffietti, James Perry, Pierre Giglio, Macarena de la Fuente, Elizabeth A. Maher, Steven Schoenfeld, Dan Zhao, Shuchi S. Pandya, Lori Steelman, Islam Hassan, Patrick Y. Wen, Timothy F. Cloughesy
New England Journal of Medicine. 2023755 CitationsOPEN ACCESS
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Burt Nabors, Jana Portnow, Manmeet S. Ahluwalia, Joachim M. Baehring, Henry Brem, Steven Brem, Nicholas Butowski, Jian Campian, Stephen W. Clark, Andrew J. Fabiano, Peter Forsyth, Jona A. Hattangadi‐Gluth, Matthias Holdhoff, Craig Horbinski, Larry Junck, Thomas Kaley, Priya Kumthekar, Jay S. Loeffler, Maciej M. Mrugała, Seema Nagpal, Manjari Pandey, Ian F. Parney, Katherine B. Peters, Vinay K. Puduvalli, Ian Robins, Jason K. Rockhill, Chad G. Rusthoven, Nicole Shonka, Dennis C. Shrieve, Lode J. Swinnen, Stephanie E. Weiss, Patrick Y. Wen, Nicole E. Willmarth, Mary Anne Bergman, Susan Darlow
Journal of the National Comprehensive Cancer Network. 2020575 CitationsOPEN ACCESS
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research
Smita Bhatia, Wendy Landier, Electra D. Paskett, Katherine B. Peters, Janette K. Merrill, Jonathan Phillips, Raymond U. Osarogiagbon
JNCI Journal of the National Cancer Institute. 2022305 CitationsOPEN ACCESS
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Ingo K. Mellinghoff, Marta Peñas-Prado, Katherine B. Peters, Howard A. Burris, Elizabeth A. Maher, Filip Jankú, Gregory M. Coté, Macarena I. de la Fuente, Jennifer Clarke, Benjamin M. Ellingson, Saewon Chun, Robert J. Young, Hua Liu, Sung Choe, Min Lu, Kha Le, Islam Hassan, Lori Steelman, Shuchi S. Pandya, Timothy F. Cloughesy, Patrick Y. Wen
Clinical Cancer Research. 2021267 CitationsOPEN ACCESS
Related on ScholarIQ
Duke University
Institution
Recurrent Glioblastoma Treated with Recombinant Poliovirus
Paper
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Paper
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Paper
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research
Paper
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Paper